Why is Philogen SpA ?
- Poor long term growth as Operating profit has grown by an annual rate 99.83% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.46
- NET SALES(HY) Higher at EUR 308.82 MM
- ROCE(HY) Highest at 89.63%
- DIVIDEND PAYOUT RATIO(Y) Highest at 11.53%
- Over the past year, while the stock has generated a return of 6.73%, its profits have risen by 421.4% ; the PEG ratio of the company is 0
- The stock has generated a return of 6.73% in the last 1 year, much lower than market (Italy FTSE MIB) returns of 27.29%
How much should you hold?
- Overall Portfolio exposure to Philogen SpA should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Philogen SpA for you?
Low Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Higher at EUR 308.82 MM
Highest at 89.63%
Highest at 11.53%
Fallen by -109.47% (YoY
Highest at EUR 379.22 MM
Lowest at -98.51 %
Highest at 14.36 times
Highest at 20.74 times
Highest at EUR 20.74
Highest at EUR 272.92 MM
Highest at EUR 276.18 MM
Highest at EUR 245.2 MM
Highest at EUR 6.07
Here's what is working for Philogen SpA
Pre-Tax Profit (EUR MM)
Net Profit (EUR MM)
Net Sales (EUR MM)
Operating Profit (EUR MM)
Pre-Tax Profit (EUR MM)
Net Profit (EUR MM)
EPS (EUR)
Cash and Cash Equivalents
Debt-Equity Ratio
Inventory Turnover Ratio
Debtors Turnover Ratio
DPS (EUR)
DPR (%)
Raw Material Cost as a percentage of Sales
Depreciation (EUR MM)
Depreciation (EUR MM)






